Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Accumulated Expenses (2017 - 2025)

Historic Accumulated Expenses for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to $9.7 million.

  • Neuronetics' Accumulated Expenses fell 1553.94% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year decrease of 1553.94%. This contributed to the annual value of $12.8 million for FY2024, which is 177.05% up from last year.
  • Per Neuronetics' latest filing, its Accumulated Expenses stood at $9.7 million for Q3 2025, which was down 1553.94% from $10.6 million recorded in Q2 2025.
  • Neuronetics' Accumulated Expenses' 5-year high stood at $14.8 million during Q4 2022, with a 5-year trough of $5.2 million in Q1 2021.
  • Over the past 5 years, Neuronetics' median Accumulated Expenses value was $9.3 million (recorded in 2025), while the average stood at $9.5 million.
  • Per our database at Business Quant, Neuronetics' Accumulated Expenses soared by 8021.38% in 2022 and then plummeted by 1553.94% in 2025.
  • Neuronetics' Accumulated Expenses (Quarter) stood at $8.2 million in 2021, then surged by 80.21% to $14.8 million in 2022, then fell by 15.11% to $12.6 million in 2023, then grew by 1.77% to $12.8 million in 2024, then fell by 24.69% to $9.7 million in 2025.
  • Its Accumulated Expenses was $9.7 million in Q3 2025, compared to $10.6 million in Q2 2025 and $9.3 million in Q1 2025.